Hazards of widespread use of erythromycin for preterm prelabour rupture of membranes.
Tan
Susern
S
Holliman
R
R
Russell
A R Bedford
AR
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D017723:Drug Utilization Review; D004917:Erythromycin / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000188:drug therapy* / Q000382:microbiology; D019983:Guideline Adherence / Q000706:statistics & numerical data; D006300:Health Services Misuse; D006801:Humans; D006967:Hypersensitivity / Q000382:microbiology; D007231:Infant, Newborn; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011247:Pregnancy; D012307:Risk Factors; D006113:United Kingdom
D000900:Anti-Bacterial Agents; D004917:Erythromycin